This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Bookman MA , Greer BE , Ozols RF
Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG158) and an update on GOG0 182-ICON5
International Journal of Gynecological Cancer. 2003 Nov-Dec;13(6) :735-740
AbstractMature results from GOG158 have clearly established carboplatin and paclitaxel as an effective and well tolerated standard regimen, providing a basis for the reference arm in GOG0182-ICON5, an ongoing multiarmed phase III trial of the Gynecologic Cancer InterGroup (GCIG) evaluating the incorporation of newer cytotoxic agents. Results from GOG158 will be reviewed, including an analysis of second-look surgical outcomes, followed by an update on the current status of GOG0182-ICON5.
NotesEnglish Review Bookman, MA; *Fox* *Chase* Canc Ctr, Div Med Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA. Research Addresses: *Fox* *Chase* Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA. Univ Washington, Sch Med, Div Gynecol Oncol, Seattle, WA USA. Cited References: PARMAR MKB, 2002, LANCET, V360, P505 BOOKMAN MA, 2003, J CLIN ONCOL, V21, PS149 BOOKMAN MA, 1996, J CLIN ONCOL, V14, P1895 DUBOIS A, 1999, P AN M AM SOC CLIN, V18, P1374 GREER BE, 2003, GYNECOL ONCOL, V88, P156 MCGUIRE WP, 1996, NEW ENGL J MED, V334, P1 MUGGIA FM, 2000, J CLIN ONCOL, V18, P106 NEIJT JP, 2000, J CLIN ONCOL, V18, P3084 OZOLS RF, 1999, P AN M AM SOC CLIN, V18, P1373 OZOLS RF, 2003, J CLIN ONCOL, V21, P3194 PICCART MJ, 2000, J NATL CANCER I, V92, P699 VERMORKEN JB, 1993, ANN ONCOL, V4, P41 Number of cited references: 12 Number of times cited: 0 Publisher: BLACKWELL PUBLISHING INC; 350 MAIN ST, MALDEN, MA 02148 USA. 1048-891X